iScribe and insurance firm reduce rates for docs

Article

iScribe and insurance firm reduce rates for docsIn one of the more unpredictable alliances resulting from the Institute of Medicine report on medical errors, San Mateo, CA-based iScribe has closed an agreement with The Doctors’ Company

iScribe and insurance firm reduce rates for docs

In one of the more unpredictable alliances resulting from the Institute of Medicine report on medical errors, San Mateo, CA-based iScribe has closed an agreement with The Doctors’ Company whereby TDC will reduce malpractice premiums for physicians who use the iScribe prescription-writing system. The Napa, CA-based insurer plans to offer the incentive initially to physicians writing the highest number of prescriptions. iScribe will provide its handheld prescription-writing system to physicians on TDC’s plan free of charge starting in the third quarter of 2000. iScribe’s prescription-writing software checks for drug interactions and formulary information and automatically updates the prescription database (HNN 5/3/00).

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.